Date:
Thursday, July 4, 2013

It is with great sadness that we inform you of the death of Prof. Gerd Döring on July 2.

Gerd served as President of the ECFS from 1998 to 2006...Read more

Date:
Thursday, June 20, 2013

At the 2013 Lisbon conference, European National CF Associations present their continued support towards the ECFS Clincial Trials Network.


The ECFS is very grateful for the continuing collaboration and...Read more

Date:
Monday, June 17, 2013

ECFS Award, Young Investigator Awards, Best Poster Awards

ECFS Award - Prof. Kevin Webb

ECFS Award 2013 ...Read more

Date:
Sunday, May 12, 2013

The ECFS CTN is seeking to employ a half-time Quality Manager.  Deadline for applications has been extended to 5 June 2013

Clinical Trials Network - Quality Manager

The European Cystic...Read more

Date:
Tuesday, May 7, 2013

Free access to articles

Date:
Wednesday, May 1, 2013

The April 2013 ECFS CTN Newsletter

Year 5 Issue 1

ECFS-CTN at present

...Read more

The ECFS-CTN has entered its fifth year of activity and it is

Date:
Sunday, March 31, 2013

Best Poster Awards

 Malaga Best Poster Awards

...Read more

Yiting Wang (United Kingdom)
Thermodynamic analysis of

Date:
Tuesday, January 8, 2013

For services to Healthcare in Northern Ireland, Prof. Stuart Elborn has received a CBE in the UK 2013 New Year Honours list.

Date:
Friday, November 23, 2012

The European Cystic Fibrosis Society (ECFS) is looking to appoint the next Director for the  ECFS Patient Registry

Background

The purpose of the ECFS Patient Registry (ECFSPR) is to measure,...Read more

Date:
Tuesday, September 25, 2012

The European Cystic Fibrosis Society (ECFS) is looking to appoint the next Editor-in-Chief of the Journal of Cystic Fibrosis (JCF).

The current Editor-in-Chief, Gerd Döring, will complete his mandate on...Read more

Date:
Friday, July 27, 2012

Vertex Receives European Approval for KALYDECO™ (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis in People With a Specific Genetic Mutation (G551D)

Vertex Pharmaceuticals Incorporated...Read more

Date:
Monday, June 25, 2012

At the 2012 Dublin conference, European National CF Associations present their continued support towards the ECFS Clincial Trials Network.

Date:
Friday, June 8, 2012

ECFS Award 2012 - Prof. Niels Høiby

Professor Niels Høiby
Prof. Niels Høiby (right) receiving the award from ECFS President Prof. Stuart Elborn

...Read more

Date:
Wednesday, February 1, 2012

The ECFS welcomes the approval of Vertex’s KALYDECO (ivacaftor) by the FDA.

Press release available here (external site)

Update from May 25, 2012

Vertex Receives European CHMP Positive Opinion for KALYDECO™...Read more

Date:
Wednesday, July 13, 2011

4 workshops open to external participants included in a pilot PhD programme on: "Molecular and Cellular Biology of the Epithelium in Health and Disease at the University of Lisbon".

Published...Read more

Date:
Wednesday, April 6, 2011

Award Winners at the 8th Basic Science Conference held in Tirrenia, Italy 30 March - 2 April 2011


The ECFS thanks the Chairpersons of the 8th Basic Science Conference:...Read more

Date:
Thursday, March 17, 2011

Young Investigator Awards and Travel Grants

The Scientific Committee of the 34th ECFS Conference has, as part of the abstract review process, selected the abstracts they have deemed...Read more

Date:
Friday, February 25, 2011

A message from the ECFS President and the Director of the ECFS Clinical Trials Network 

The recent trial of VX770 in patients with G551D mutations has reported its...Read more

Date:
Friday, November 5, 2010

Focus of this CF awareness campaign is once more on access to care.